Holen Sie sich die Stockscreener-App
4.32
2.26%
-0.10
Schlusskurs vom Vortag:
$4.42
Offen:
$4.42
24-Stunden-Volumen:
146.61K
Relative Volume:
1.44
Marktkapitalisierung:
$215.43M
Einnahmen:
$15.33M
Nettoeinkommen (Verlust:
$-40.19M
KGV:
-2.4655
EPS:
-1.7522
Netto-Cashflow:
-
1W Leistung:
-6.49%
1M Leistung:
-8.67%
6M Leistung:
-22.16%
1J Leistung:
+1.89%
1-Tages-Spanne:
$4.21
$4.46
1-Wochen-Bereich:
$4.21
$4.85
52-Wochen-Spanne:
$3.42
$5.88
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
Firmenname
Trisalus Life Sciences Inc
Sektor
Branche
Telefon
415 336 8917
Adresse
6272 WEST 91ST AVENUE, WESTMINSTER
Vergleichen Sie TLSI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
4.32 | 220.41M | 15.33M | -40.19M | 0 | -1.7522 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-13 | Eingeleitet | Lake Street | Buy |
| 2024-12-17 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-11-11 | Eingeleitet | ROTH MKM | Buy |
| 2024-10-25 | Eingeleitet | Northland Capital | Outperform |
| 2024-09-16 | Eingeleitet | Oppenheimer | Outperform |
| 2024-05-30 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Trisalus Life Sciences Inc Aktie (TLSI) Neueste Nachrichten
What high frequency data says about TriSalus Life Sciences Inc.Profit Target & Fast Moving Trade Plans - newser.com
Will breakout in TriSalus Life Sciences Inc. Equity Warrant lead to full recoveryStop Loss & Long-Term Growth Stock Strategies - newser.com
Will TriSalus Life Sciences Inc. stock gain from strong economyJuly 2025 Trade Ideas & Free Real-Time Market Sentiment Alerts - newser.com
Automated trading signals detected on TriSalus Life Sciences Inc. Equity WarrantMarket Risk Analysis & Reliable Price Action Trade Plans - newser.com
Is it time to cut losses on TriSalus Life Sciences Inc.July 2025 PostEarnings & Real-Time Volume Analysis - newser.com
Published on: 2025-10-10 09:12:22 - newser.com
Will TriSalus Life Sciences Inc. stock deliver strong dividend growthJuly 2025 Weekly Recap & Daily Profit Focused Stock Screening - newser.com
Sentiment analysis tools applied to TriSalus Life Sciences Inc.Quarterly Portfolio Report & Growth Focused Entry Reports - newser.com
TriSalus Life Sciences' (TLSI) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
Published on: 2025-10-09 04:25:24 - newser.com
Volume spikes in TriSalus Life Sciences Inc. Equity Warrant stock – what they meanQuarterly Profit Review & AI Powered Market Entry Ideas - newser.com
Relative strength of TriSalus Life Sciences Inc. in sector analysisJobs Report & Short-Term Swing Trade Alerts - newser.com
Tick level data insight on TriSalus Life Sciences Inc. volatilityShare Buyback & Free Weekly Watchlist of Top Performers - newser.com
How TriSalus Life Sciences Inc. stock reacts to oil pricesJuly 2025 Outlook & Long-Term Safe Investment Ideas - newser.com
Quantitative breakdown of TriSalus Life Sciences Inc. recent moveMarket Weekly Review & Low Risk Growth Stock Ideas - newser.com
Will TriSalus Life Sciences Inc. outperform the marketWeekly Trend Report & Consistent Income Trade Ideas - newser.com
Using Bollinger Bands to evaluate TriSalus Life Sciences Inc. Equity Warrant2025 Historical Comparison & Accurate Intraday Trade Tips - newser.com
Is it too late to sell TriSalus Life Sciences Inc.July 2025 Update & Low Drawdown Trading Techniques - newser.com
How hedge fund analytics apply to TriSalus Life Sciences Inc. Equity Warrant stockJuly 2025 Fed Impact & Low Drawdown Investment Strategies - newser.com
How to build a custom watchlist for TriSalus Life Sciences Inc. Equity WarrantRecession Risk & Trade Opportunity Analysis - newser.com
Tools to monitor TriSalus Life Sciences Inc. Equity Warrant recovery probabilityTrade Analysis Summary & Safe Capital Allocation Plans - newser.com
What analysts say about TriSalus Life Sciences Inc stockHigh Beta Stocks & High Profit Market Tips - earlytimes.in
TriSalus Life Sciences director Sean Murphy resigns from board By Investing.com - Investing.com Canada
TriSalus Life Sciences director Sean Murphy resigns from board - Investing.com India
33,900 Shares in TriSalus Life Sciences, Inc. $TLSI Bought by Goldman Sachs Group Inc. - Defense World
Finanzdaten der Trisalus Life Sciences Inc-Aktie (TLSI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Trisalus Life Sciences Inc-Aktie (TLSI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Devlin Jodi | Chief of Clinical Operations |
May 19 '25 |
Sale |
5.18 |
4,764 |
24,678 |
52,764 |
| Marshak Richard | Chief Commercial Officer |
May 19 '25 |
Sale |
5.18 |
6,597 |
34,172 |
69,101 |
| Stevens Jennifer | Chief Regulatory Officer |
May 19 '25 |
Sale |
5.18 |
8,704 |
45,087 |
77,640 |
| Young James Emmett | Chief Financial Officer |
Feb 05 '25 |
Buy |
5.65 |
6,000 |
33,900 |
30,000 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 30 '25 |
Buy |
5.28 |
5,010 |
26,453 |
444,259 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 29 '25 |
Buy |
5.03 |
5,030 |
25,301 |
439,249 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 27 '25 |
Buy |
5.42 |
4,826 |
26,157 |
429,503 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 28 '25 |
Buy |
5.12 |
4,716 |
24,146 |
434,219 |
| Murphy Sean | Chief Manuf, Strategy&Bus Dev. |
Jan 27 '25 |
Buy |
5.31 |
15,000 |
79,650 |
182,732 |
| Murphy Sean | Chief Manuf, Strategy&Bus Dev. |
Jan 28 '25 |
Buy |
5.17 |
15,000 |
77,550 |
197,732 |
1.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):